Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test C-erbB-2 (HER-2/neu) Test Immunohistochemistry is typically 5-7 business days. However, this may vary depending on the specific laboratory and their processing times.

What are the prerequisites for the test C-erbB-2 (HER-2/neu) Test Immunohistochemistry

  • Formalin-fixed, paraffin-embedded tissue block or unstained slides
  • Requisition form with patient information and test requested
  • Properly labeled specimen container
  • Completed test request form with relevant clinical information
  • Proper storage and transportation of specimen to the laboratory

What are the measure values for the test C-erbB-2 (HER-2/neu) Test Immunohistochemistry

  • 0: No staining observed or membrane staining in < 10% of tumor cells
  • 1+: Faint/barely perceptible partial membrane staining in > 10% of tumor cells
  • 2+: Weak to moderate complete membrane staining in > 10% of tumor cells
  • 3+: Strong complete membrane staining in > 10% of tumor cells

What does this test C-erbB-2 (HER-2/neu) Test Immunohistochemistry identify?

The C-erbB-2 (HER-2/neu) Test Immunohistochemistry is a diagnostic test that identifies the presence of a protein called HER-2/neu in breast cancer cells. This protein is known to promote the growth of cancer cells and is associated with more aggressive forms of breast cancer.

The test involves staining breast cancer tissue samples with antibodies that specifically bind to the HER-2/neu protein. The presence and amount of staining can help determine if the cancer cells overexpress the HER-2/neu protein, which can guide treatment decisions.

If the test results show HER-2/neu overexpression, targeted therapies such as Herceptin may be recommended to specifically target and inhibit the HER-2/neu protein, leading to improved outcomes for patients with HER-2 positive breast cancer.

Why is this test C-erbB-2 (HER-2/neu) Test Immunohistochemistry taken?

The C-erbB-2 (HER-2/neu) Test Immunohistochemistry is taken to determine the presence of the HER-2/neu protein in breast cancer cells. This test is important because HER-2/neu is a protein that promotes the growth of cancer cells. Patients who have breast cancer that is positive for HER-2/neu may benefit from targeted therapies that specifically target this protein. Therefore, the results of this test can help guide treatment decisions and improve outcomes for patients with breast cancer.

No FAQs available.

Customer Google Rating